rajiv72
15 Mar 2019
why all of sudden iodine crude price increased is there a shortage
Tentative Predator
30 Apr 2018
Disappointing The thing that really matters here is cash. So I saw the headline "Cash balances increased from US$2.8m to US$3.4m" and thought excellent! Finally they are actually making some money to pay back those huge loans. But no, buried in the notes is that the cash balance has gone up because they pulled the cash from their $3m loan facility. And they haven't had a penny spare to pay back the interest on the loans, instead rolling it all up.Their loans have increased from $18.5m at end 2016 to $25.3m at end 2017. It's now 13 months from repayment. The final loan amount due is likely to be around $30m. Obviously there's is no chance it can be repaid, in fact it looks like they won't be cash generative enough by then to pay even a penny off. So once again the company is in the situation where it desperately needs refinancing - because if not the loan holders can take over all it's assets with no recompense to shareholders.So I'm afraid if you haven't heard by September that there is an arrangement to refinance the loans (I'm being really time generous, realistically you'd hear in the next month if they're going to manage), then the shares will be worthlessThe loan refinancing is the ONLY thing that matters here, everything else is distraction.Sorry for the bad news. (I'm not a holder, I was once but sold at a profit and been following it since)
the old trout
02 Apr 2018
Supply squeeze in Chile It is well known that Chile is the major producer of Iodine in world markets but things have now been going well for them with two of the smaller producers going out of business and now the major producer SQM has big problems:[link] extraction of water in the Salar de Llamara is appropriately 124 liters per second and is used to supply the Pampa Hermosa plant, located in the commune of Pozo Almonte, where it works on the production of 6,500 tons of iodine per year.For now, the cause was under study so that SQM will not be able to authorize the extraction of water until a verdict is generated, a situation that calls into question the fulfillment of its annual goal of iodine extraction."If this ban becomes permanent, it is likely to have a significant effect on market prices for Iodine and IOF's bottom line.T
the old trout
16 Mar 2018
Seller cleared? Multiple algo trades on the ask today between 12:11 and 12:34. Then the 645k buy at 12:46 which was reported after the market closed. Hopefully that has taken out the last of the supply, clearing the way for at least a retest of the recent high around 25p.The chart also seems to be pointing towards a breakout:[link]
Ecologist
14 Dec 2017
End of year update Promising[link]
nk1999
22 Sep 2017
H1 results Seems good news"Iofina, specialists in the exploration and production of iodine, and iodine and other halogen based specialty chemical derivatives, is pleased to announce positive Interim Results for the six months ended 30 June 2017 (the "Period"
. During this Period the Group achieved a number of significant financial and operational milestones and accordingly looks forward to the rest of the year with increased optimism. In particular, during the period the Group significantly improved EBITDA performance, focused resources on the planning of the new IO#7 plant which is now under construction, and exceeded the revised production targets announced following the closure of IO#3 plant. The Group's IOsorb® plants produced 235.5 metric tonnes ("MT" in H1 2017 which exceeded our expectations of 215-230 MT of production following the closure of IO#3. The Board expects the Group to produce between 225-240 MT of crystalline iodine in H2 2017 from its four IOsorb® plants in operation. Alongside improving operational performance, the outlook for the Group is increasingly positive in terms of both revenue and profitability, given that spot iodine prices have already risen by approximately 25% to $24/kg since the start of the year. Moving forward the Group will be significantly increasing iodine production whilst also reducing the unit cost of production. Having controlled costs and managed the business efficiently during a period of low iodine prices the Group is confident it stands well placed to take advantage of an improving underlying marketplace....."
biotech billy
04 May 2017
Re: and??? Hi Ecologist,I think that the share price rise is due to a more optimistic outlook for Iodine prices. This optimism is based, at least in part, on production issues in Chile.BB
Ecologist
03 May 2017
and??? Not a mention on here since early March. Has everyone disappeared to the good ship LSE??Why the jump in the last few days? After all, the last trading update was 11th April - 3 weeks ago.
EyesonHawk2
02 Mar 2017
Re: Sudden increase Iodine stocks reducing+world demand rising = Iodine prices positive and rising.Will we see an sp fall tomorrow or the momentum kept up. Maybe an RNS Friday?
Gooffy
02 Mar 2017
Sudden increase News coming??Anyone expecting anything??
Tentative Predator
01 Oct 2016
Interim I have to commend the board on the clearest most transparent set of results they've ever produced. Nothing is hidden afaict. They've finally put the water rights behind them (it was originally worth pursuing, but they dragged it on and spent lots of money way after it was obviously not going to happen). They're still putting money into mineral rights ($370k) which I can't see any positives for, but I'll give them the benefit of the doubt. The restructuring terms and liabilities are clear.They're no longer claiming any real visibility on Iodine price, none of the old "it's stabilising". The outlook is explained with complete clarity, still on the downward trend, no likelihood of any immediate improvement; long term forecast of above $30 which if you look at the trend over 30 years is completely reasonable, especially with demand continuing to increase. Historically low inventories suggest that the market agrees that the downtrend is still in place (if the market thought the price had bottomed they'd be buying at the current price to build inventories before the price goes up; instead while they think the price is continuing to drop they continue to use existing stock because they'll get it cheaper later). And continuing oversupply.The financial position is clear. They can't make enough to pay off the debts, even if they cut costs further - in fact it doesn't seem like they can cut costs any further. If you dig in to the figures, without the loan interest they'd be roughly cashflow neutral (there's a roughly equivalent inflow from stock decrease and outflow from the mineral rights); the loan interest is the net reason the for cash decrease. The new loans let them rollup the interest if they want, and together with the $10m loan facility that means they don't have cashflow problems. But of course just having the amount you owe go up each year without making any more cash is not going to benefit the shareholders.So the strategy they're going to follow is double or nothing. They're going to compete headfirst in the global oversupply by adding yet more supply. New plants will be commissioned and using their existing expertise they'll aim for a cost of production which matches the current low price levels. Basically, they're saying to the other producers "we're going to produce ever more until 2019, and if any of you swerve, we reckon our creditors will roll over and let us continue even after that". Yes, it's a global game of Iodine production chicken. It's not a bet that's worth taking if you don't already hold shares. It's also their only realistic option, other than just doing nothing and hoping the Iodine price will go up - and "hope" is not really a viable strategic alternative.The shame is that if they had been this sensible all along, this would now be profit making, with no loans and growing fast. Lots of ill-advised detours, but I guess thats all in the past now. Good luck to you shareholders.
nk1999
11 Aug 2016
Re: baffling Must be because they confirmed that they will meet the production targets in their main activity. Share price has been beaten down quite a lot recently, so steady output must be a good news?nk
camperdown
11 Aug 2016
baffling it loses the court case and the sp increases 14%. cmon
pharmajiles
03 Aug 2016
Re: Debt Restructure 'Well done IOF, I am a very happy bunny'---------- ---------- ---------- ---------- ----If ignorance is bliss…………I'd think you're the happiest bunny in the entire world………...
Tentative Predator
13 Jun 2016
Re: 2015 FY + loan restructure This is a win-win-win deal. From the company's point of view, it's a stay of execution on the loans, potentially a 1 for 2 rights issue which is good value for the current price, and the new loan facility is invaluable here and now. For shareholders this places a likely bottom on the price for now (it could go down from here but not by much, and it could certainly go up). For the lenders it's a great deal: a good interest rate in the current environment if the price doesn't rise, a good conversion price if it does, and in the worst case scenario of management failing or Iodine prices staying low, they get the entire company as senior debtors in 2019 - instead of a company in chapter 11 next year and haggling to get assets.Well done IOF. Now you need luck, the price of Iodine needs to start an uptrend, even if it's a really slow uptrend.
